Year-on-Year Variations:
- 2025: 2.65%
- 2026: 3.23%
- 2027: 2.50%
- 2028: 2.44%
Compound Annual Growth Rate (CAGR) (2024-2028): 2.71%
The sales of systemic hormonal preparations in Canada, excluding sex hormones and insulins, show a steady upward trend from 2024 to 2028. This growth is driven by increasing awareness of hormonal disorders and advancements in hormonal therapies. Future trends to watch include the potential impact of new drug approvals, changes in healthcare policies, and evolving patient demographics.
